MedPath

Speed of Injection and Pain During Routine Infant Vaccinations

Phase 3
Conditions
Routine Infant Immunizations
Pain Management
Interventions
Other: Fast injection speed by immunizer
Other: Slow injection speed by immunizer
Registration Number
NCT02504398
Lead Sponsor
University of Toronto
Brief Summary

Vaccine injections are a significant source of pain for infants. Altering the injection speed when administering vaccines may be an effective intervention and is feasible (cost neutral). At present, there are no data regarding impact of injection speed on vaccine injection pain in infants. The aim of this study is to address this knowledge gap and to compare the impact of slow and fast vaccine injection speeds on pain during routine infant vaccinations.

Detailed Description

To date, there has been no evidence-based guidance regarding the rate at which vaccines should be injected to minimize pain. This has led to a disparity in practice. Some vaccinators favour a slow rate of injection (around 8-10 sec/mL) while others prefer a more rapid rate of injection (around 2-4 sec/mL).The slow injection method leads to a longer needle dwelling time with the increased possibility of the needle moving around and causing pain by damaging muscle tissue. Rapid injection, on the other hand, may lead to a sudden distension of muscle tissue, which itself could be painful. Allowing the muscle sufficient time to distend in order to accommodate the vaccine might minimize pain. This study will address the identified knowledge gap by comparing pain in infants undergoing routine vaccinations with a fast vs. slow injection speed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Healthy 2 and 4 month old infants receiving their primary vaccine injections, PediacelTM (0.5mL) and PrevnarTM (0.5mL) (in conjunction with and preceded by oral RotarixTM vaccine) and healthy 6 month old infants receiving their routine vaccine injection, PediacelTM (0.5mL)
Exclusion Criteria
  • Infants with impaired neurological development; history of seizures; administration of sedatives or narcotics in the preceding 24 hours; parental inability to use study tools; parent vaccine refusal; prior participation in the trial; and refusal to be video recorded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fast injectionFast injection speed by immunizerVaccine injections will be given at a rate of approximately 2-4 ml/sec by the immunizer
Slow injectionSlow injection speed by immunizerVaccine injections will be given at a rate of approximately 10 ml/sec by the immunizer
Primary Outcome Measures
NameTimeMethod
Infant Behavioural Pain Scoreup to 1 minute post-vaccinations

Assessed using the Modified Behavioural Pain Scale (0-10) from videotapes of the procedure

Secondary Outcome Measures
NameTimeMethod
Infant Parent-rated Pain Scoreup to 2 minutes

Assessed using a Numerical Rating Scale (0-10) by parent in real time

Infant Cry durationup to 2 minutes

Assessed in 1 minute intervals for 2 minutes following vaccinations from videotapes

Trial Locations

Locations (1)

Pediatric Consultants

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath